查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1953518

行為障礙治療市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、療法、地區和競爭格局分類，2021-2031年）

Disruptive Behavior Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Treatment, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球破壞性行為障礙治療市場預計將從 2025 年的 186 萬美元成長到 2031 年的 257 萬美元，複合年成長率為 5.54%。

該市場涵蓋多種藥物和心理治療干預措施，旨在管理行為問題，例如對立性反抗症和品行障礙。這一成長趨勢主要得益於臨床上對兒童精神疾病的認知不斷提高，以及健全的診斷框架的引入，從而實現早期療育。政府加大投入，致力於將精神健康服務與基層醫療系統整合，進一步強化了這些潛在促進因素。世界衛生組織（世衛組織）強調了治療管理的迫切需求，並估計到2025年，全球約有3.3%的10至14歲青少年患有品行障礙。

市場概覽
預測期 2027-2031
市場規模：2025年 186萬美元
市場規模：2031年 257萬美元
複合年成長率：2026-2031年 5.54%
成長最快的細分市場 行為障礙
最大的市場 北美洲

儘管成長指標積極，但市場仍面臨一個重大障礙：全球兒童精神科醫生和心理健康專業人員嚴重短缺。人力不足導致患者診斷和治療服務嚴重受阻，這問題在發展中地區尤為突出。因此，訓練有素的醫療保健人員短缺限制了治療方案的廣泛實施，儘管臨床需求旺盛，但市場潛在規模卻受到抑制。

市場促進因素

對立性反抗症 (ODD) 和品行障礙 (CD) 盛行率的上升是市場擴張的主要促進因素，也因此迫切需要更多治療選擇。行為障礙診斷數量的增加反映了青少年整體心理健康狀況的下降，從而推動了對藥物治療和心理社會干預的需求。根據美國疾病管制與預防中心 (CDC) 於 2024 年 8 月發布的《2013-2023 年青少年風險行為調查資料摘要和趨勢報告》，到 2023 年，約 40% 的高中生將經歷持續的悲傷或絕望感，這凸顯了加強對行為健康服務的迫切需求。為了服務不斷成長的患者群體，醫療保健提供者正面臨壓力，需要實施更積極的診斷和治療通訊協定，以應對日益增加的行為障礙症狀。

與臨床需求同步成長的還有政府對兒童心理健康領域的投入，這些投入顯著增加，旨在減少就醫障礙並補貼治療費用。聯邦和州政府機構正在增加津貼，將行為健康服務融入學校和社區中心，從而擴大直接服務對象。例如，美國藥物濫用和精神健康服務管理局 (SAMHSA) 在 2024 年 7 月的新聞稿中宣布了一項 1530 萬美元的專項撥款，用於透過校內心理健康服務支持兒童，並為患有嚴重情緒障礙的兒童提供支持。公共投資的激增也帶動了私部門的樂觀情緒。根據 MedCity News 2024 年 10 月的一篇文章報道，2023 年，專注於青少年心理健康的數位健康Start-Ups獲得的投資佔數位行為健康領域總資金籌措的 34%。

市場挑戰

全球行為障礙治療市場面臨的一大阻礙因素是兒童精神科醫師和心理健康專業人員的全球短缺。這種短缺在醫療保健服務系統中造成了嚴重的瓶頸，因為診斷行為障礙等疾病以及後續的藥物和心理治療管理都需要持證專業人員的嚴格監督。如果沒有足夠的專業人員來滿足臨床需求，患者的等待時間將顯著延長，許多診斷甚至會被完全漏診，從而有效地阻礙了潛在患者積極使用治療產品。

這種結構性限制顯著縮小了潛在市場規模，無論疾病盛行率或診斷意識如何。醫療服務提供者短缺的問題在關鍵的醫療保健統計數據中得到了清晰的體現：根據美國兒童和青少年精神病學會的數據，截至2024年，美國約有72%的縣沒有配備兒童和青少年精神科醫生。這種專科醫師的嚴重短缺意味著治療性介入無法惠及廣大民眾，從而抑制了市場收入成長，並限制了治療提供者的有效覆蓋範圍。

市場趨勢

數位療法與人工智慧驅動的分析技術的融合，正使基於軟體的干涉措施成為可報銷的標準治療方案，從根本上改變了市場格局。這些處方箋級應用程式利用人工智慧提供認知行為療法並即時追蹤症狀，有效彌補了行為障礙兒童患者就診間隔時間的不足。聯邦監管機構建立正式的支付體系，進一步鞏固了該方法的商業性可行性，並直接推動了醫療服務提供者的採用。在2024年11月發布的《2025會計年度醫療保險醫師收費標準最終規則》中，美國醫療保險和醫療補助服務中心最終確定了三個專門用於數位心理健康治療設備的新的HCPCS代碼，從而建立了明確的報銷途徑，獎勵將這些技術整合到行為健康計劃中。

此外，住院和門診護理模式的擴展導致了精神科服務的去中心化，從以機構為基礎的通訊協定轉向以家庭為中心的遠距管理。遠距精神科基礎設施為這一轉變提供了支持，使專業人員能夠在家庭環境中開展直接的家長培訓，從而克服了地域限制和醫護人員嚴重短缺的問題。這種護理模式轉變的持久性體現在其高使用率上，即使在疫情初期需求激增之後，其使用率仍然居高不下。根據加州公共衛生部於2024年6月發布的《兒童遠距心理健康照護》報告，青少年遠距心理健康服務的使用率比疫情前水準增加了30倍，凸顯了市場向門診照護和技術賦能的治療方式的長期調整。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

5. 全球顛覆性行為障礙治療市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（對立性反抗症、品行障礙、間歇性暴怒障礙）
    • 治療方法類型（藥物管理、全面評估、家庭治療、教養指導、團體治療、個別治療、社交和情緒技能訓練）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美破壞性行為障礙治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲破壞性行為障礙治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區行為障礙治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲破壞性行為障礙治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲破壞性行為障礙治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球破壞性行為障礙治療市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Eli Lilly and Company
  • Pfizer Inc.
  • Johnson & Johnson
  • Boston Children's Hospital
  • INTEGRIS Health
  • H. Lundbeck A/S
  • Springwoods Behavioral Health
  • PrairieCare, LLC
  • Valley Children's Healthcare
  • Impireum Psychiatric Group

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27306

The Global Disruptive Behavior Disorder Treatment Market is projected to expand from USD 1.86 million in 2025 to USD 2.57 million by 2031, registering a compound annual growth rate of 5.54%. This market encompasses various pharmaceutical and psychotherapeutic interventions aimed at managing behavioral issues such as Oppositional Defiant Disorder and Conduct Disorder. The growth trajectory is primarily supported by the increasing clinical recognition of pediatric psychiatric conditions and the adoption of strong diagnostic frameworks that allow for earlier intervention. These foundational drivers are further strengthened by growing government financial support intended to merge mental health services with primary care systems. Highlighting the significant need for therapeutic management, the World Health Organization estimates that conduct disorder will affect approximately 3.3% of adolescents aged 10-14 years globally in 2025.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.86 MIllion
Market Size 2031USD 2.57 MIllion
CAGR 2026-20315.54%
Fastest Growing SegmentConduct Disorder
Largest MarketNorth America

Despite these positive growth indicators, the market faces a substantial obstacle in the form of a severe global shortage of specialized child psychiatrists and mental health professionals. This lack of a sufficient workforce creates critical bottlenecks in diagnosing patients and delivering treatments, a problem that is particularly acute in developing regions. As a result, the scarce availability of trained providers limits the widespread implementation of therapeutic regimens, effectively restricting the potential market size even in the face of high clinical demand.

Market Driver

The rising prevalence of Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) acts as the main engine for market expansion, creating an urgent need to scale up therapeutic options. This increase in behavioral diagnoses reflects a wider decline in adolescent psychological well-being, fueling the demand for both medication-based and psychosocial interventions. Data from the Centers for Disease Control and Prevention's 'Youth Risk Behavior Survey Data Summary & Trends Report: 2013-2023', released in August 2024, reveals that roughly 40% of high school students experienced persistent feelings of sadness or hopelessness in 2023, emphasizing the severe need for enhanced behavioral health services. This expanding patient population forces healthcare providers to implement more aggressive diagnostic and treatment protocols to handle the increasing volume of disruptive behavioral symptoms.

Alongside this clinical demand is a significant increase in government-funded initiatives for pediatric mental health, which helps reduce barriers to care and subsidizes the cost of treatment. Both federal and state authorities are increasingly distributing grants to embed behavioral health services within schools and community centers, thereby directly widening the addressable market. For example, the Substance Abuse and Mental Health Services Administration announced in a July 2024 press release that it had awarded $15.3 million specifically to support children through school-based mental health services and aid for those with serious emotional disturbances. This surge in public investment is matched by private sector optimism; according to MedCity News in October 2024, investments in digital health startups focused on youth mental health represented 34% of all digital behavioral health funding in 2023.

Market Challenge

A severe constraint on the Global Disruptive Behavior Disorder Treatment Market is the critical global shortage of specialized child psychiatrists and mental health professionals. This deficit in the workforce creates a significant bottleneck within the healthcare delivery system because diagnosing conditions like Conduct Disorder and managing subsequent pharmaceutical or psychotherapeutic regimens demand strict supervision by licensed specialists. When the number of available professionals is insufficient to meet clinical needs, patient wait times increase dramatically, and numerous diagnoses are missed completely, effectively stopping potential patients from becoming active users of therapeutic products.

This structural limitation substantially shrinks the addressable market size, irrespective of how prevalent the disease is or how much diagnostic awareness exists. The gap in provider availability is clearly reflected in major healthcare statistics. According to the American Academy of Child and Adolescent Psychiatry, approximately 72% of counties in the United States did not have practicing child and adolescent psychiatrists in 2024. Such a profound lack of specialists implies that therapeutic interventions cannot reach a vast segment of the population, thereby impeding market revenue growth and limiting the effective scope of treatment providers.

Market Trends

The integration of Digital Therapeutics and AI-Driven Analytics is establishing software-based interventions as a reimbursed standard of care, which is fundamentally reshaping the market landscape. These prescription-grade applications employ artificial intelligence to administer cognitive behavioral therapy and track symptoms in real-time, effectively bridging the gap between clinical appointments for pediatric patients exhibiting disruptive behaviors. The commercial viability of this approach was solidified when federal regulators established formal payment structures, directly encouraging adoption by providers. In the 'Calendar Year (CY) 2025 Medicare Physician Fee Schedule Final Rule' released in November 2024, the Centers for Medicare & Medicaid Services finalized three new HCPCS codes specifically for digital mental health treatment devices, establishing a clear reimbursement pathway that incentivizes incorporating these technologies into behavioral treatment plans.

Furthermore, the expansion of home-based and outpatient care models is decentralizing psychiatric services, moving them toward remote, family-centered management and away from protocols that rely heavily on facilities. This transition is supported by tele-psychiatry infrastructure, which permits specialists to conduct behavioral parent training directly within the home setting, thereby surmounting geographic hurdles and severe provider shortages. The enduring nature of this shift in care delivery is demonstrated by utilization rates that remain high well past the initial urgency of the pandemic. According to the California Department of Public Health's 'Tele-Mental Health Care for Children' report from June 2024, the use of tele-mental health services for youth has sustained a 30-fold increase compared to pre-pandemic levels, highlighting the market's long-term reorientation toward outpatient and technology-enabled therapeutic access.

Key Market Players

  • Eli Lilly and Company
  • Pfizer Inc.
  • Johnson & Johnson
  • Boston Children's Hospital
  • INTEGRIS Health
  • H. Lundbeck A/S
  • Springwoods Behavioral Health
  • PrairieCare, LLC
  • Valley Children's Healthcare
  • Impireum Psychiatric Group

Report Scope

In this report, the Global Disruptive Behavior Disorder Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Disruptive Behavior Disorder Treatment Market, By Type

  • Oppositional Defiant Disorder
  • Conduct Disorder
  • Intermittent Explosive Disorder

Disruptive Behavior Disorder Treatment Market, By Treatment

  • Medication Management
  • Comprehensive Evaluation
  • Family Therapy
  • Parenting Modification
  • Group Therapy
  • Individual Therapy
  • Social
  • Emotional Skills Training

Disruptive Behavior Disorder Treatment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Disruptive Behavior Disorder Treatment Market.

Available Customizations:

Global Disruptive Behavior Disorder Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Disruptive Behavior Disorder Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Oppositional Defiant Disorder, Conduct Disorder, Intermittent Explosive Disorder)
    • 5.2.2. By Treatment (Medication Management, Comprehensive Evaluation, Family Therapy, Parenting Modification, Group Therapy, Individual Therapy, Social, Emotional Skills Training)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Disruptive Behavior Disorder Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Treatment
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Disruptive Behavior Disorder Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Treatment
    • 6.3.2. Canada Disruptive Behavior Disorder Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Treatment
    • 6.3.3. Mexico Disruptive Behavior Disorder Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Treatment

7. Europe Disruptive Behavior Disorder Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Treatment
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Treatment
    • 7.3.2. France Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Treatment
    • 7.3.3. United Kingdom Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Treatment
    • 7.3.4. Italy Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Treatment
    • 7.3.5. Spain Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Treatment

8. Asia Pacific Disruptive Behavior Disorder Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Treatment
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Treatment
    • 8.3.2. India Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Treatment
    • 8.3.3. Japan Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Treatment
    • 8.3.4. South Korea Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Treatment
    • 8.3.5. Australia Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Treatment

9. Middle East & Africa Disruptive Behavior Disorder Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Treatment
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Disruptive Behavior Disorder Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Treatment
    • 9.3.2. UAE Disruptive Behavior Disorder Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Treatment
    • 9.3.3. South Africa Disruptive Behavior Disorder Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Treatment

10. South America Disruptive Behavior Disorder Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Treatment
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Disruptive Behavior Disorder Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Treatment
    • 10.3.2. Colombia Disruptive Behavior Disorder Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Treatment
    • 10.3.3. Argentina Disruptive Behavior Disorder Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Treatment

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Disruptive Behavior Disorder Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Eli Lilly and Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Pfizer Inc.
  • 15.3. Johnson & Johnson
  • 15.4. Boston Children's Hospital
  • 15.5. INTEGRIS Health
  • 15.6. H. Lundbeck A/S
  • 15.7. Springwoods Behavioral Health
  • 15.8. PrairieCare, LLC
  • 15.9. Valley Children's Healthcare
  • 15.10. Impireum Psychiatric Group

16. Strategic Recommendations

17. About Us & Disclaimer